Concepedia

Wei Chua

WC

Statistics

Publications

24

Citations

2.1K

H-Index

15

Active since

2009

Affiliations

Liverpool Hospital(Current)

UNSW Sydney

Western Sydney University

Ingham Institute

South Western Sydney Local Health District

Wei Chua is an author at Liverpool Hospital specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2009–2025

24

Publications

24

[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

Michael S. Hofman, Louise Emmett, Shahneen Sandhu et al. · The Lancet · 2021 · 1.1K citations

, , +12

Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial

Michael S. Hofman, Louise Emmett, Shahneen Sandhu et al. · The Lancet Oncology · 2023 · 199 citations

, , +16

[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial

Louise Emmett, Shalini Subramaniam, Megan Crumbaker et al. · The Lancet Oncology · 2024 · 155 citations

, , +12

Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes

Mohammed Nimir, Yafeng Ma, Sarah A. Jeffreys et al. · Cells · 2019 · 67 citations · Full text

, , +17

Droplet Digital PCR Based Androgen Receptor Variant 7 (AR-V7) Detection from Prostate Cancer Patient Blood Biopsies

Yafeng Ma, Alison W. S. Luk, Francis Young et al. · International Journal of Molecular Sciences · 2016 · 65 citations · Full text

, , +17

1–5 of 24